Neuroscience, Inflammatory Disorders and Therapeutics

Joan Y.W. Liu, Lawrence Binding, Isha Puntambekar, Smriti Patodia, Yau Lim, Alicja Mrzyglod, Fenglai Xiao, Shengning Pan, Remika Mito, Jane deTisi, John S Duncan, Sallie Baxendale, Matthias Koepp and Maria Thom 2024. Microangiopathy in temporal lobe epilepsy with diffusion MRI alterations and cognitive decline. Acta Neuropathologica Communications. https://doi.org/10.21203/rs.3.rs-4841682/v1

Smith, C.L. 2024. Challenges of developing and delivering authentic assessments. Teaching and Learning Conference 2024: Future-Focused Education: Innovation, Inclusion, and Impact. Nottingham Trent University - City campus 02 - 04 Jul 2024 Advance HE.

Audu, D., Patel, V.B., Idowu, O.A., Mshelbwala, F.M. and Idowu, A.B. 2023. Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c). Egyptian Liver Journal. 13 53. https://doi.org/10.1186/s43066-023-00291-7

Morad, H. 2022. Repurposing the antimalarial compound artemisinin as a novel therapy for inflammatory conditions. Drug Repurposing II. Woburn House, London, UK 10 - 11 May 2022 The Biochemical Society.

Hassan Morad, Suaib Luqman, Chun-Hsiang Tan and Peter McNaughton 2021. TRPM2 ion channels steer neutrophils towards a source of hydrogen peroxide. Dynamic Cell IV. 14 - 19 Mar 2021 The Biochemical Society.

Hassan Morad, Suaib Luqman and Peter McNaughton 2017. O30 Natural compounds affecting neutrophil migration. ICMAN/ IUPHAR Natural Products. Aberdeen, Scotland 27 - 29 Sep 2017 Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2017.06.095

Morad, H. 2014. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro. Royal Society of Medicine, Clinical Immunology and Allergy Conference. University of Cambridge Sep - Oct 2014 Royal Society of Medicine.